Internal Medicine, Gastroenterology · Paducah, KY
NPI
1083856041
Since 2009
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1532 Lone Oak Rd, Suite 310
Paducah, KY, 42003
Phone (270) 443-0777
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
1,214 services
Medicare patients, 2024
657
Average age 72
Drug cost, 2024
$713K
1,837 prescriptions
Company payments, 2025
$63.26
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ross E Jones was code 43239 (upper gi endoscopy), 248 times for 235 patients. In total Ross E Jones billed 1,214 services in 53 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 248 | 235 | $45.95 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 125 | 123 | $98.51 | $12K |
| 43248 Upper GI Endoscopy | Facility | 114 | 107 | $91.18 | $10K |
| 45385 Colonoscopy - Lesion Removal | Facility | 113 | 112 | $191.87 | $22K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 73 | 73 | $164.38 | $12K |
| 45378 Lower GI Endoscopy - Other | Facility | 55 | 54 | $119.45 | $6,570 |
| 74328 Digestive/Gastrointestinal | Facility | 51 | 39 | $16.71 | $852 |
| 43264 Upper GI Endoscopy | Facility | 46 | 37 | $50.12 | $2,306 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 42 | 42 | $157.16 | $6,601 |
| 43259 Upper GI Endoscopy | Facility | 41 | 41 | $139.29 | $5,711 |
| 43242 Upper GI Endoscopy | Facility | 34 | 31 | $180.94 | $6,152 |
| 43274 Upper GI Endoscopy | Facility | 31 | 26 | $298.72 | $9,260 |
| 43235 Upper GI Endoscopy | Facility | 28 | 26 | $76.91 | $2,153 |
| 99213 Office E&M - Established | Office | 23 | 18 | $49.19 | $1,131 |
| 43275 Upper GI Endoscopy | Facility | 19 | 19 | $251.54 | $4,779 |
By year: 2022 $138K for 1,203 services; 2023 $122K for 1,117 services; 2024 $132K for 1,214 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ross E Jones prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 551 prescriptions and refills. In total Ross E Jones wrote 1,837 Medicare prescriptions that cost $713K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 551 | 551 | 536 | $13K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 277 | 277 | 267 | $3,932 |
| Pantoprazole Sodium Generic | 171 | 314 | 73 | $2,437 |
| Omeprazole Generic | 156 | 218 | 77 | $947 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 92 | 92 | 89 | $1,588 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 89 | 100 | 87 | $6,125 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 89 | 89 | 88 | $1,496 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 56 | 56 | 54 | $906 |
| Sucralfate Generic | 48 | 56 | 24 | $9,375 |
| Linzess Linaclotide | 36 | 40 | 16 | $21K |
| Humira(Cf) Pen Adalimumab | 26 | 26 | Under 11 | $272K |
| Creon Lipase/Protease/Amylase | 17 | 23 | Under 11 | $56K |
| Mesalamine Generic | 16 | 30 | Under 11 | $11K |
| Ursodiol Generic | 14 | 30 | Under 11 | $2,856 |
| Motegrity Prucalopride Succinate | 14 | 14 | Under 11 | $7,429 |
Brand drugs: 424 claims; generic drugs: 1,413 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ross E Jones $63.26 ($63.26 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $63.26.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $63.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.